Five Prime Therapeutics, Inc. News Headlines

Get FPRX Alerts
*Delayed - data as of Apr. 22, 2014 
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    FPRX Pre-Market
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
Basic Chart Interactive Chart
Company Headlines Press Releases Market Stream
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Filtered By
Ordered By

Should Five Prime Therapeutics (FPRX) Be On Your Radar Now? - Tale of the Tape
4/10/2014 8:53:01 AM - Zacks.com

FPRX To Present At Needham Healthcare Conference; Webcast At 4:20 PM ET
4/8/2014 3:00:00 PM - RTT News

Earnings Estimates Moving Higher for Five Prime (FPRX): Time to Buy? - Tale of the Tape
4/4/2014 8:47:01 AM - Zacks.com

Bristol Myers Deal Overshadows Q4 loss at Five Prime - Analyst Blog
3/27/2014 11:00:01 AM - Zacks.com

Five Prime Therapeutics Q4 13 Earnings Conference Call At 5:00 PM ET
3/25/2014 3:00:00 PM - RTT News

Bristol-Myers, Five Prime Join Forces, Shares up - Analyst Blog
3/18/2014 12:00:01 PM - Zacks.com

Five Prime Therapeutics (FPRX) Surges: Stock Moves 22.6% Higher - Tale of the Tape
3/18/2014 9:18:01 AM - Zacks.com

ATEC Sees Growth, FPRX Gets High-Five, RNA Walks The Talk, RPRX On The Move
3/18/2014 1:39:00 AM - RTT News

Five Prime Therapeutics (FPRX) Is Rising On BMY Collaboration News
3/17/2014 9:50:00 AM - RTT News

Five Prime And Bristol-Myers Squibb To Collaborate On Immuno-oncology
3/17/2014 9:40:00 AM - RTT News

U.S. Hot Stocks: Hot Stocks to Watch
3/17/2014 9:22:00 AM - Dow Jones Business News

Five Prime Therapeutics To Present At Roth Conference; Webcast At 8:30 PM ET
3/11/2014 3:03:00 PM - RTT News

Five Prime Therapeutics Prices 3 Mln Shares At $12.50 Per Share - Quick Facts
2/7/2014 12:08:00 AM - RTT News

Five Prime: A Growing Oncology And Inflammatory Player With A Promising Pipeline
10/30/2013 2:47:00 PM - Seeking Alpha

Five Prime Therapeutics - Another Risky Cancer Research Public Offering
9/23/2013 7:05:00 AM - Seeking Alpha

Five Prime Therapeutics prices IPO at $13, within the range
9/17/2013 8:08:06 PM - Renaissance Capital

IPO Preview: Five Prime Therapeutics
9/17/2013 4:34:00 PM - Seeking Alpha

12 U.S. IPOs Planned For The Week Of September 16
9/16/2013 3:57:00 PM - Seeking Alpha

U.S. IPO Recap: Benefitfocus, Six Others Set Terms As Calendar Rebuilds
9/10/2013 8:21:00 AM - Seeking Alpha

US IPO Recap: Benefitfocus, six others set terms as calendar rebuilds
9/8/2013 10:23:54 PM - Renaissance Capital

Biotech Five Prime Therapeutics sets terms for $52 million IPO
9/4/2013 5:43:04 PM - Renaissance Capital

U.S. IPO Recap: 11 Deals Prince In Busiest Week Since November 2007, 8 Companies Set Terms
7/30/2013 7:27:00 AM - Seeking Alpha

Biotech Five Prime Therapeutics files for a $60 million IPO
7/28/2013 3:55:32 PM - Renaissance Capital